Global Amoxicillin Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029
Amoxicillin is an antibiotic often used for the treatment of a number of bacterial infections. It may be used for middle ear infection, strep throat, pneumonia, skin infections, and urinary tract infections among others. It is taken by mouth, or less commonly by injection.
Market Overview:The latest research study on the global Amoxicillin market finds that the global Amoxicillin market reached a value of USD 4926.66 million in 2022. It’s expected that the market will achieve USD 5322.14 million by 2028, exhibiting a CAGR of 1.3% during the forecast period.
Affected by COVID-19
The global economy and humanity are in crisis during the COVID-19 pandemic. Due to the high infection rate and adverse impact on public health systems of COVID-19, governments have imposed nationwide lockdowns, which have had a major impact on manufacturing supply chains, trade and related services. The epidemic has caused travel restrictions, supply chain disruptions, uncertainty in the stock market, and a decline in business confidence, which has affected the production of the amoxicillin industry. As a result, production, manufacturing, supply chain and other operations across the globe have slowed down during the COVID-19 pandemic in an effort to limit the spread of the coronavirus, and various factors have worked against the amoxicillin industry. With the control of the epidemic, industrial production and operations have gradually resumed.
Supply chain of amoxicillin industry affected
During the COVID-19 outbreak, governments have taken corresponding measures to curb the spread of the epidemic, restricting the movement of people, and strengthening control measures such as cross-border logistics. The supply chain of the amoxicillin industry is affected. First of all, the procurement of raw materials in the amoxicillin industry is blocked, and the production enterprises are faced with the problem of lack of work and materials, thus hindering the production of related enterprises. The second is the inability to send the goods to buyers, resulting in a backlog of inventory. At present, with the improvement of the global epidemic, the supply chain of the amoxicillin industry has been restored.
Amoxicillin is widely used
Antibiotics are important for treating infections and have saved countless lives. As an antibiotic, amoxicillin can be used to treat a variety of bacterial infections. Examples include middle ear infections, strep throat, pneumonia, skin infections, and urinary tract infections.
Amoxicillin is widely used in clinical practice. For example, it can be used for the treatment of otitis media, sinusitis, acute pharyngitis, acute tonsillitis, genitourinary infections, skin and soft tissue infections, acute bronchitis, pneumonia, acute simple gonorrhea and other diseases. In addition, amoxicillin can also be used to treat typhoid fever, typhoid carriers and leptospirosis; Amoxicillin can also be used in combination with clarithromycin and lansoprazole to eradicate Helicobacter pylori in stomach and duodenum and reduce the recurrence rate of gastrointestinal ulcer. Therefore, a wide range of uses drives the development of the amoxicillin industry.
Rising energy costs
At present, due to the influence of the global macroeconomic environment, energy costs are relatively rising. Russia is a major player in the global energy market. It is one of the top three crude oil producers in the world. Russia is also the world's second-largest natural gas producer after the United States and has the world's largest natural gas reserves. Russia is an important energy exporter in the world. The Russian-Ukrainian war reduced global energy supplies and affected global energy prices.
For the amoxicillin industry, rising energy prices have increased the cost of energy required to produce and sell amoxicillin.
Impact of Environmental Policy
The pharmaceutical industry is affected by a series of environmental protection policies. For example, in 2017, China introduced a series of environmental protection policies, increased environmental protection efforts, and set off an environmental protection storm. Affected by this, some enterprises stopped production for rectification, and the production of amoxicillin APIs dropped sharply for a period of time, which affected the development of the amoxicillin industry.
Region Overview:In global comparison, a significant portion of the revenue was generated in North America (23.98% in 2022).
Company Overview:GSK is one of the major players operating in the Amoxicillin market, holding a share of 10.52% in 2023.
GSK
GlaxoSmithKline was formed in 2000 from the merger of Glaxo Wellcome plc and SmithKline Beecham plc, both companies with a history of mergers. GSK is a pharmaceutical manufacturer whose main products include prescription drugs, vaccines and consumer healthcare products.
Cipla
Cipla is an Indian multinational pharmaceutical company. Cipla develops medicines for respiratory diseases, cardiovascular diseases, arthritis, diabetes, depression and many other diseases. Cipla has expanded to more than 80 countries, offering more than 1,500 products in more than 50 dosage forms across different therapeutic classes. To make healthcare more affordable globally, Cipla is deepening Cipla's presence in key markets such as India, South Africa, the US and other emerging world economies.
Segmentation Overview:Among different product types, Capsule segment is anticipated to contribute the largest market share in 2028.
Capsule
Amoxicillin capsules are packed in capsules, and the capsules are filled with drugs in powder or granular state without mechanical extrusion. When taking amoxicillin capsules, it can also avoid the effect of drug odor on taking the drug, and can reduce the discomfort caused by the odor.
Tablet
Capsules and tablets are two different pharmaceutical dosage forms. Amoxicillin tablets are made by fusing the drug ingredients with some excipients.
Application Overview:The market's largest segment by application is the segment Retail Pharmacy, with a market share of 53.87% in 2022.
Hospital Pharmacy
The hospital pharmacy is one of the key departments of the hospital, responsible for the procurement, storage, preparation, dispensing, testing, packaging and distribution of medicines. Patients buy medicines at the hospital pharmacy according to the prescription drug list after seeing a doctor in the hospital.
Retail Pharmacy
Retail pharmacy refers to offline retail pharmacies.
Online Pharmacy
An online pharmacy refers to an online pharmacy that buys online and delivers medicines by courier.
Key Companies in the global Amoxicillin market covered in Chapter 3:GSK
USAntibiotics
Cipla
Centrient Pharma
Teva
LKPC
United Laboratories
Aurubindo
HPGC
Hikma
CSPC
Dr. Reddy
NCPC
In Chapter 4 and Chapter 14.2, on the basis of types, the Amoxicillin market from 2018 to 2029 is primarily split into:Capsule
Tablet
Others
In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Amoxicillin market from 2018 to 2029 covers:Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)